chemotherapy does not improve the survival
rate of patients with small cell lung cancer
(SCLC), a new Swiss study concludes.
on 140 patients in a randomized trial showed
no statistically significant differences
in survival rate or tumor size between groups
receiving either standard or high doses
of chemo over a three-year period. The findings
were published online April 8 in the Journal
of the National Cancer Institute.
thought upping the amount of chemotherapy
might help the patients live longer because
laboratory data had suggested that higher
doses kill SCLC cells resistant to standard